Pharmaceutical Access

image alt text
Photo: Olaf Starorypinski, Lehigh Valley Children's Hospital, Allentown, Pennsylvania

Latest Update

  • Congresswoman Doris Matsui, D-Calif., introduces pro-340B bill, CHA endorses
  • CHA submits comments on the Administration's Drug Pricing Blueprint


Analysis or Summary
International Pricing Index Model for Medicare Part B Drugs
November 14, 2018

CMS released an advance notice of proposed rulemaking with comment that describes a new model for reimbursing select Medicare Part B drugs.

Analysis or Summary
President Signs Opioid Package
October 22, 2018

The President signed into law H.R. 6, the SUPPORT for Patients and Communities Act.

How Children's Hospitals are Confronting the Opioid Crisis
October 18, 2018

Explore stories of how hospitals are creating new programs and best practices to address opioid use.

Letter or Testimony
CHA sends letter to H.R. 6 conferees highlighting pediatric provisions
September 20, 2018

CHA sent a letter to the conferees this week regarding an amended version of H.R. 6, the SUPPORT for Patients and Communities Act.

Analysis or Summary
FY 2019 Medicare IPPS Rule Summary and Comment Letter
September 18, 2018

The Centers for Medicare & Medicaid Services (CMS) released its FY 2019 Medicare Hospital Inpatient Prospective Payment System (IPPS) and Long-Term ...

Analysis or Summary
Administration's Drug Price Blueprint and Request for Information
July 17, 2018

CHA prepared a high-level summary of the Blueprint to lower drug prices and reduce out-of-pocket costs. Member hospitals are encouraged to review it ...

Letter or Testimony
CHA Endorses Pro-340B Legislation
June 19, 2018

CHA issued a letter of support for H.R. 6071, the SERV Communities Act.

Talking Points
How 340B Helps Hospitals
June 15, 2018

The federal 340B program supports children's hospitals in their mission to serve low-income, uninsured and under-insured patients.

Letter or Testimony
CHA Comments on Proposed Delay to 340B Ceiling Price and Manufacturer Civil Monetary Penalties Regulation
May 23, 2018

CHA joined the 340B Coalition and allied hospital groups and submitted joint comments in response to the Department of Health and Human Services’ ...

Letter or Testimony
CHA thanks Senate HELP leadership for pediatric measures in opioid package
May 10, 2018

This week CHA sent a letter thanking leaders of the Senate H.E.L.P committee for the inclusion of pediatric measures within S.2680.

Analysis or Summary
Comparison of Recent 340B Program Legislative Proposals
April 13, 2018

A comparison of the recent legislative proposals relating to the 340B Drug Pricing Program.

Letter or Testimony
Comment Letter on the 340B PAUSE ACT Submitted
February 21, 2018

On Feb. 16, CHA sent a letter to Reps. Larry Buschon, R-Ind., and Scott Peters, D-Calif., expressing concerns with H.R. 4710, the 340B Protecting ...

Analysis or Summary
Summary of H.R. 4710, the 340B PAUSE Act
February 1, 2018

A summary of H.R. 4710, the 340B PAUSE Act, which proposes a two-year moratorium on new DSH hospitals and new DSH hospital child sites.

Reference Material
Children's Hospitals Enrolled in the 340B Drug Pricing Program
January 26, 2018

The 340B Drug Pricing Program allows eligible health care organizations to purchase outpatient drugs at discounted prices. The following children's ...

Analysis or Summary
Summary of S.2312, the HELP Act
January 25, 2018

S.2312, the HELP Act, proposed a two-year moratorium on new 340B DSH child sites.

Letter or Testimony
CHA Letter to FDA on PREA Orphan Drug Loophole Guidance
January 25, 2018

CHA and allies applaud the FDA's recent draft guidance on the Clarification of Orphan Designation of Drugs and Biologics for Pediatric Subpopulations ...

Letter or Testimony
CHA Comments on the Delayed 340B Ceiling Price and Manufacturer Civil Monetary Penalties Regulation
September 20, 2017

CHA comments on the delayed 340B ceiling price and manufacturer civil monetary penalties regulation from Oct. 1 to July 1, 2018.

Letter or Testimony
Allied Organizations Urge Congress to Include Pediatric Provisions within FDARA
May 5, 2017

CHA, in conjunction with allied provider and disease groups, sent a letter to House and Senate leadership within the Energy and Commerce Committee ...

Letter or Testimony
CHA Submits Joint Comments on the 340B Administrative Dispute Resolution Proposed Rule with the 340B Coalition
October 12, 2016

CHA, in coordination with the 340B Coalition, submitted comments to the Health Resources and Services Administration (HRSA) on the proposed ...

Letter or Testimony
340B Coalition Submits Comments on 340B Drug Pricing Program
May 25, 2016

The 340B Coalition submitted supplemental comments on the proposed rule addressing the ceiling price and manufacturer civil monetary penalties.

Working Together on Drug Pricing and Shortages
April 26, 2016

Children's hospitals are working together to address drug pricing and drug shortages to improve affordability and access to lifesaving drugs.

Letter or Testimony
CHA Comments on Medicare Off-campus Provider-based Requirements
February 19, 2016

CHA submitted comments to the House Committee on Energy & Commerce to provide feedback on changes to Medicare payment policies included in the ...

Presentation or Recording
Recent Changes to Medicare Off-campus Provider-based Requirements and Implications for Children's Hospitals
February 18, 2016

Alston & Bird, LLP, prepared a presentation for CHA members on Medicare off-campus provider-based requirements.

Analysis or Summary
2015 State Policy Trends Identified Through Member Outreach
January 29, 2016

During the summer and fall of 2015, the Policy Analysis team reached out to government relations professionals to inform our understanding of the ...

Letter or Testimony
340B Omnibus Guidance Comments to HRSA
October 27, 2015

CHA submitted comments to HRSA in response to the proposed 340B omnibus guidance.



The Capitol building.

Government Relations Toolkit
CHA members can view and print the latest materials for outreach to federal and state lawmakers.

Policy Update Calls

Members receive the latest updates and suggest ways to best influence policy issues that impact children's health and children's hospitals in a weekly conference call.